Sumitomo Pharma Co., Ltd. (DNPUF)
9.27
+0.86
(+10.29%)
USD |
OTCM |
Aug 25, 16:00
Sumitomo Pharma EPS Diluted (Quarterly) : 0.2448 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.2448 |
| March 31, 2026 | -0.013 |
| December 31, 2025 | 0.144 |
| September 30, 2025 | 1.496 |
| June 30, 2025 | 0.1951 |
| March 31, 2025 | 0.0399 |
| December 31, 2024 | 0.8829 |
| September 30, 2024 | -0.8124 |
| June 30, 2024 | 0.2574 |
| March 31, 2024 | -3.344 |
| December 31, 2023 | -0.8504 |
| September 30, 2023 | -0.5028 |
| June 30, 2023 | -0.7113 |
| March 31, 2023 | -1.065 |
| December 31, 2022 | -0.1997 |
| September 30, 2022 | -0.6986 |
| June 30, 2022 | 0.6031 |
| March 31, 2022 | 0.2176 |
| December 31, 2021 | 0.2193 |
| September 30, 2021 | 0.7236 |
| June 30, 2021 | 0.1105 |
| March 31, 2021 | -0.333 |
| December 31, 2020 | 0.794 |
| September 30, 2020 | 0.4515 |
| June 30, 2020 | 0.4274 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.0745 |
| December 31, 2019 | 0.316 |
| September 30, 2019 | 0.554 |
| June 30, 2019 | 0.1535 |
| March 31, 2019 | 0.1978 |
| December 31, 2018 | 0.2701 |
| September 30, 2018 | 0.285 |
| June 30, 2018 | 0.3516 |
| December 31, 2017 | -0.0322 |
| September 30, 2017 | 0.4645 |
| June 30, 2017 | 0.5576 |
| March 31, 2017 | -0.0129 |
| December 31, 2016 | 0.4286 |
| September 30, 2016 | 0.0628 |
| June 30, 2016 | 0.1952 |
| March 31, 2016 | 0.0295 |
| December 31, 2015 | 0.21 |
| September 30, 2015 | 0.1499 |
| June 30, 2015 | 0.1231 |
| March 31, 2015 | -0.0749 |
| December 31, 2014 | 0.1591 |
| September 30, 2014 | 0.1453 |
| June 30, 2014 | 0.1419 |
| March 31, 2014 | 0.0221 |
| December 31, 2013 | 0.2623 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 0.2213 |
| Daiichi Sankyo Co., Ltd. | 0.2366 |
| Eisai Co., Ltd. | 0.1015 |
| Chugai Pharmaceutical Co., Ltd. | 0.2218 |
| Santen Pharmaceutical Co., Ltd. | 0.1399 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 106.66M |
| Revenue (Quarterly) | 812.63M |
| Total Expenses (Quarterly) | 705.96M |
| Enterprise Value | 4.675B |
| Gross Profit Margin (Quarterly) | 52.57% |
| Profit Margin (Quarterly) | 13.13% |
| Earnings Yield | 20.20% |
| Operating Earnings Yield | 8.30% |
| Normalized Earnings Yield | 20.20 |